A proposed federal rule aims to clear the way for retirement savings plans to include alternative assets. But it may not be enough to protect employers from lawsuits.
Read MoreThe war with Iran is preventing huge amounts of oil from flowing out of the Persian Gulf, but the prices that many people track don’t fully capture the scale of the disruption.
Read MoreThe Treasury secretary and the Fed chairman reportedly summoned banking leaders to discuss the potential systemic risks of Anthropic’s new model.
Read MoreQuestions about how freely ships can pass through the waterway have pushed up oil prices and weighed on stocks.
Read MoreInvestors were in a more sober mood after sharp moves on the previous day.
Read MoreAnalysts and traders are anxiously watching the Strait of Hormuz and whether peace talks can resolve big differences between the United States and Iran.
Read MoreOil prices are rising and stocks are selling off as investors fret that the president will carry out his threats to “decimate” Iran.
Read MoreThe complex transaction pitched by the billionaire hedge fund manager would need to pass muster with the music giant’s shareholders.
Read MoreIn his annual letter to shareholders, Jamie Dimon, the chief executive of JPMorgan Chase, said investors and businesses faced a series of challenges.
Read MoreThe White House’s attacks on academia and budget cuts for research have provided an opening for other countries to poach leading scientists.
Read MoreThe average rate on a 30-year mortgage in the United States jumped to 6.46 percent, making it harder for buyers to afford homes.
Read MoreOil surged and stocks sold off after the president delivered an unclear case for continuing the war in the Middle East.
Read MoreGlobal markets rallied as President Trump signaled that the United States may stop fighting soon. But big questions remain about lingering damage.
Read MoreThe average price of gasoline in the U.S. has topped $4 a gallon, a multiyear high, as war in the Middle East roils the oil market and slams drivers.
Read MoreWith elite athletes like LeBron James and Cristiano Ronaldo as investors, the company, now valued at $10 billion, is courting everyday health enthusiasts.
Read More
